Back to Archived Journals » Oncolytic Virotherapy » Volume 6 » default

Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Oncolytic Virotherapy

ISSN: 2253-1572


       

Archive: Volume 6, 2017

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect

Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ

Oncolytic Virotherapy 2017, 6:39-49

Published Date: 8 November 2017

Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity

Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y

Oncolytic Virotherapy 2017, 6:31-38

Published Date: 13 March 2017

Proinflammatory response induced by Newcastle disease virus in tumor and normal cells

Ginting TE, Suryatenggara J, Christian S, Mathew G

Oncolytic Virotherapy 2017, 6:21-30

Published Date: 3 March 2017

Editorial announcing PubMed indexing of Oncolytic Virotherapy

Farassati F

Oncolytic Virotherapy 2017, 6:19-20

Published Date: 15 February 2017

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma

Babiker HM, Riaz IB, Husnain M, Borad MJ

Oncolytic Virotherapy 2017, 6:11-18

Published Date: 9 February 2017

Novel oncolytic viral therapies in patients with thoracic malignancies

Ahmad Z, Kratzke RA

Oncolytic Virotherapy 2017, 6:1-9

Published Date: 21 December 2016